Norvège -
norvégien -
Statens legemiddelverk
vimco vet -
laboratorios hipra.s.a. - staphylococcus aureus stamme sp 140, inaktivert - injeksjonsvæske, emulsjon
Union européenne -
norvégien -
EMA (European Medicines Agency)
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
Norvège -
norvégien -
Statens legemiddelverk
verucid 11 g/100 g / 4 g/100 g / 1.1 mg/100 g
galderma nordic ab - salisylsyre / melkesyre / kobberacetat - liniment, oppløsning - 11 g/100 g / 4 g/100 g / 1.1 mg/100 g